Countries covered: United States
Now 25% off the original sale price of $3,250.
This Kalorama Information report focuses on major product categories, including cardiovascular, analgesic, central nervous system, gastrointestinal, anti-infective and cancer drugs. Updated to include the most pressing issues and trends facing the generic industry—GATT legislation, patent changes, industry consolidation, managed care and mandatory
Substitution—the report provides revenue data for 1994 through 1997 and forecasts the market through 2002. Comprehensive profiles of industry leaders and niche competitors are included.
|
- Chapter One: Executive Summary
Market Size and Forecast
Historical Period
Forecast Period
The Products
Product Descriptions
Prescription Generic Cardiovascular Drugs
Calcium Channel Blockers
Angina and Arrhythmia
Vasodilators, Vasopressors, and Anticoagulants
Beta Blockers
Diuretics
Prescription Generic Anti-Infective Drugs
Prescription Generic Respiratory and Allergy Drugs
Asthma and Bronchodilators
Antihistamines and Decongestants
Cough Preparations
Prescription Generic Central Nervous System and Psychotherapeutic Drugs
Sedatives, Tranquilizers, and Antianxiety Drugs
Antidepressants and Antipsychotics
Anticonvulsants, Antispasmodics, and Muscle Relaxants
Prescription Generic Analgesic, NSAIDs, and Antiarthritic Drugs
Analgesics
NSAIDs
Antiarthritics
Prescription Generic Gastrointestinal Drugs
Gastrointestinal
Digestants
Antidiarrheals
Antispasmodics
Antinauseants
Prescription Generic Hormone Drugs
Reproductives and Contraceptives
Steroids
Diabetes
Thyroid
Prescription Generic Cancer Drugs
Chemotherapeutic Agents
Chemotherapeutic Adjuvants
Prescription Generic Ophthalmic Drugs
Trends Affecting the Market
Generic Approvals
Consolidation Trends in the Industry
Legislation Affecting the Industry
Industry Structure and Leading Competitors
Scope and Methodology
- Chapter Two: The Product
Introduction
Market Segmentation
Overview
Cardiovascular Disease
Calcium Channel Blockers
Angina and Arrhythmia
Vasodilators, Vasopressors, and Anticoagulants
Beta Blockers
Diuretics
Prescription Generic Anti-Infective Drugs
Prescription Generic Respiratory and Allergy Drugs
Asthma and Bronchodilators
Antihistamines and Decongestants
Cough Preparations
Prescription Generic Central Nervous System and Psychotherapeutic Drugs
Sedatives, Tranquilizers, and Antianxiety Drugs
Antidepressants and Antipsychotics
Anticonvulsants, Antispasmodics, and Muscle Relaxants
Prescription Generic Analgesic, NSAIDs, and Anti-arthritic Drugs
Analgesics
NSAIDs
Anti-Arthritics
Prescription Generic Gastrointestinal Drugs
Anti-Ulcer
Digestants
Antidiarrheals
Antispasmodics
Antinauseants
Prescription Generic Hormone Drugs
Reproductives and Contraceptives
Steroids
Diabetes
Thyroid
Prescription Generic Cancer Drugs
Chemotherapeutic Agents
Chemotherapeutic Adjuvants
Prescription Generic Ophthalmic Drugs
Ophthalmic Anti-Infectives
Ophthalmic Anti-Inflamatories
Glaucoma Agents
- Chapter Three: Issues And Trends
Development Process of Prescription Generic Drugs for Consumers
Electronic Submissions
Impact on Market for Generic Drugs
Merger and Acquisition Activity
Consolidation of Brand-Name and Generic Companies
Drug Treatment Trends
Long-Term Care Facilities
Legislation and Legal Issues
GATT Legislation
Litigation
Revisions of Waxman-Hatch Act
Other Lobbying Efforts
Organizational Issues
Bioequivalency Ratings
Impact on Market for Generic Drugs
Generic Bulk Issues
Impact on Market for Generic Drugs
Mail Order Generic Drugs
Biotech Activities
Advertising of Generic Drugs
Consumer Advertising
Controlling Costs
Impact on Market for Generic Drugs
Consumer Issues and Trends
Consumer Savings
Distribution of Prescription Generic Drugs to Consumers
The Elderly
Demographics
Research and Development and the Elderly
- Chapter Four: The Market
Scope and Methodology
Market Size and Growth
Overall Market
1997
The Prescription Generic Cardiovascular Drug Market
The Prescription Generic Anti-Infective Drug Market
The Prescription Generic Respiratory Drug Market
The Prescription Generic Central Nervous System and Psychotherapeutic Drug Market
The Prescription Analgesic, NSAID, and Antiarthritic Drug Market
The Prescription Generic Gastrointestinal Drug Market
The Prescription Generic Hormone Drug Market
The Prescription Generic Cancer Drug Market
The Prescription Generic Ophthalmic Drug Market
- Chapter Five: Competitor Profiles
Industry Structure and Participants
Akorn, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Alpharma, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Apothecon
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Barr Laboratories, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Copley Pharmaceutical, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Dey Laboratories, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
ESI Lederle
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Geneva Pharmaceuticals, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Gensia Sicor, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Mylan Laboratories, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Roxane Laboratories, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Teva Pharmaceuticals, USA
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Strategy
Watson Pharmaceuticals, Inc.
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Analysis
Zenith Goldline Laboratories
History and Lines of Business
Products in the Marketplace
Financial Information
Corporate Analysis
More United States Generics Drugs Reports
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report by
IBISWorld
Generic Pharmaceutical Manufacturing in the US Medicine for success : While this growing industry has been experiencing strong internal and external competition, the patent expirations of several ...
The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment by
AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical ...
The Pharmaceutical Market: USA (pdf/xls) by
Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
Generic Pharmaceutical Manufacturing in the US - Industry Risk Rating Report by
IBISWorld
This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Generic Pharmaceutical Manufacturing in the US industry. Industry Risk is assumed ...
Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report by
IBISWorld
Generic Pharmaceutical Manufacturing in the US Medicine for success : While this growing industry has been experiencing strong internal and external competition, the patent expirations of several ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Share this report
Other tasks Related Markets Generics Drugs Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
